Kailera Therapeutics
$12.86
5
-$0.55-4.1%Friday 20:00
+$0.00+0%Friday 23:30After hours
Statistics
Day High
12.88
Day Low
12.84
52W High
28.23
52W Low
9.76
Volume
52,349
Avg. Volume
-
Mkt Cap
1.67B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 2Expected
Q1 2026
Q2 2026
Next
-3,650
-2,433.59
-1,217.18
-0.78
Expected EPS
-1.00994
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-148.96MNet Income
Analyst Ratings
$38.00Average Price Target
The highest estimate is 48.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow KLRA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.
Show More
CEO
Ronald C. Renaud Jr.
Employees
145
Country
United States
ISIN
US4829311020
Listings
0 Comments
Share your thoughts
FAQs
What is Kailera Therapeutics stock price today?▼
The current price of KLRA is $12.86 USD — it has decreased by -4.1% in the past 24 hours. Watch Kailera Therapeutics stock price performance more closely on the chart.
What is Kailera Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Kailera Therapeutics stocks are traded under the ticker KLRA.
What is Kailera Therapeutics market cap?▼
Today Kailera Therapeutics has the market capitalization of 1.67B
When is the next Kailera Therapeutics earnings date?▼
Kailera Therapeutics is going to release the next earnings report on December 2, 2026.
What were Kailera Therapeutics earnings last quarter?▼
KLRA earnings for the last quarter are -1.09 USD per share, whereas the estimation was -0.85 USD resulting in a -28.35% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kailera Therapeutics revenue for the last year?▼
Kailera Therapeutics revenue for the last year amounts to 0 USD.
What is Kailera Therapeutics net income for the last year?▼
KLRA net income for the last year is -148.96M USD.
How many employees does Kailera Therapeutics have?▼
As of November 2, 2026, the company has 145 employees.
In which sector is Kailera Therapeutics located?▼
Kailera Therapeutics operates in the Health & Wellness sector.
When did Kailera Therapeutics complete a stock split?▼
Kailera Therapeutics has not had any recent stock splits.
Where is Kailera Therapeutics headquartered?▼
Kailera Therapeutics is headquartered in WALTHAM, United States.